Optometry 360
  • Home
  • Conferences
  • Videos
  • About Us
    • About Us – Mission
    • Media Partners
    • Advisory Board
    • Industry Council
    • Business Team

What are you looking for?

  • Conference Roundup
  • Contact Lenses
  • Diagnostics
  • Glaucoma
  • Myopia
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Retina
  • Spotlight Series
The evolving role of the optometrist in nonsurgical cataract management
Optometry 360
  • Home
  • Conferences
  • Videos
  • About Us
    • About Us – Mission
    • Media Partners
    • Advisory Board
    • Industry Council
    • Business Team
Home > Stronger myopic defocus contact lenses show short-term efficacy in slowing myopia progression
  • Contact Lenses

Stronger myopic defocus contact lenses show short-term efficacy in slowing myopia progression

Kelsey Moroz

A new randomized clinical trial (RCT) suggests that Defocus Incorporated Soft Contact (DISC) lenses with +3.50 D myopic defocus (DISC3.5plus) may slow myopia progression in children, particularly over a 6-month period.

The study, conducted from December 2018 to January 2021, involved 167 myopic children who were randomly assigned to wear either DISC3.5plus lenses or single vision (SV) soft contact lenses. At 6 months, those in the DISC3.5plus group showed significantly reduced myopia progression (-0.15 D, P = 0.02) and axial elongation (0.04 mm, P = 0.04) compared to the SV group.

However, these effects were not statistically significant at 12 months for all enrolled participants. Among those who completed the study, myopia progression remained lower in the DISC3.5plus group at both 6 and 12 months, but axial elongation differences were not significant.

The researchers noted that the COVID-19 pandemic disrupted contact lens use and follow-up, impacting the study’s long-term findings.

Reference
Zhang H, Leung KY, Leung M, et al. Myopia control using a modified optical defocus soft contact lens in schoolchildren-A 12-month randomised double masked control trial. Ophthalmic Physiol Opt. 2025;doi: 10.1111/opo.13501. Epub ahead of print. PMID: 40167121.

Share

Related Content

  • Contact Lenses

DIMS spectacle lenses noninferior to orthokeratology for slowing myopia progression in children

  • Myopia

Long-term DIMS lens users report high satisfaction despite cost barrier

  • Myopia

Low-dose atropine slowed myopia progression in children with advanced myopia in pilot trial

  • Myopia

Red-light therapy outperforms low-dose atropine in altering macular morphology

  • Myopia

Axial length monitoring may help assess myopia control success in clinical practice

  • Myopia

Switching myopia-control spectacles may temporarily slow progression in some children

Share

Advisory Board

Kaleb Abbott, OD, MS, FAAO

Clark Chang, OD

Jessica Haynes, OD, FAAO, FORS, Dipl ABO

Monica Kalia, OD

Cecelia Koetting, OD, FAAO, DipABO

Roya Attar, OD, MBA, DHA, FAAO

Hardeep Kataria, OD, FAAO

Marc R. Bloomenstein, OD, FAAO

Elise Kramer, OD

See All
Optometry 360

Optometry 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

© 2026 Optometry 360 is a trademark of International Healthcare Media, LLC. All rights Reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophthalmology360 Icon